Related content

Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation

By Artini Paolo   Monti Massimiliano   Matteucci Cristiana   Valentino Valeria   Cristello Francesca   Genazzani Andrea  

Gynecological Endocrinology, Vol. 22, Iss. 8, 2006-08 ,pp. : 465-470

Informa Healthcare

Access to resources Recommend Favorite

Raised serum levels of matrix metalloproteinase-9 in women with polycystic ovary syndrome and its association with insulin-like growth factor binding protein-1

By Liu Bin   Cai Li-Ying   Lv Hui-Ming   Xia Lei   Zhang Ya-Juan   Zhang Hong-Xiu   Guan Yong-Mei  

Gynecological Endocrinology, Vol. 24, Iss. 5, 2008-01 ,pp. : 285-288

Informa Healthcare

Access to resources Recommend Favorite

Serum levels of insulin-like growth factor-1, IGF binding protein-1 and insulin and the response to human menopausal gonadotrophins in women with polycystic ovary syndrome

By Homburg Roy   Orvieto Raoul   Bar-Hava Itai   Ben-Rafael Zion  

Human Reproduction, Vol. 11, Iss. 4, 1996-04 ,pp. : 716-719

Oxford University Press

Access to resources Recommend Favorite

Serum visfatin levels in women with polycystic ovary syndrome

By Güdücü Nilgün   İşçi Herman   Görmüş Uzay   Yiğiter Alin Başgül   Dünder Ilkkan  

Gynecological Endocrinology, Vol. 28, Iss. 8, 2012-08 ,pp. : 619-623

Informa Healthcare

Access to resources Recommend Favorite

Serum adiponectin levels in women with polycystic ovary syndrome

By Panidis Dimitrios  

Human Reproduction, Vol. 18, Iss. 9, 2003-09 ,pp. : 1790-1796

Oxford University Press

Access to resources Recommend Favorite